Targeted loss of heterozygosity in Candida albicans using CRISPR-Cas9 reveals the functional impact of allelic variation
GENETICS · 2025
DOI: 10.1093/genetics/iyaf154 ↗Kurz gefasst
Fachartikel in der Zeitschrift GENETICS, 2025. Verfasst von Philippe C Després und 5 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, United States. Hauptthemen laut MEDLINE: Candida albicans, Loss of Heterozygosity, CRISPR-Cas Systems. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: M.F., CIHR, Canada Research Chair.
Abstract (Originalsprache)
The diploid genome of the fungal pathogen Candida albicans is highly heterozygous, with most allele pairs diverging at either the coding or regulatory level. When faced with selection pressure like antifungal exposure, this hidden genetic diversity can provide a reservoir of adaptive mutations through loss of heterozygosity (LOH) events. Validating the potential phenotypic impact of LOH events observed in clinical or experimentally evolved strains can be difficult due to the challenge of precisely targeting one allele over the other. Here, we show that a CRISPR-Cas9 system can be used to overcome this challenge. By designing allele-specific guide RNA sequences, we can induce targeted, directed LOH events, which we validate by whole-genome long-read sequencing. Using this approach, we efficiently recapitulate a recently described LOH event that increases resistance to the antifungal fluconazole. Additionally, we find that the recombination tracts of these induced LOH events have similar lengths to those observed naturally. To facilitate future use of this method, we provide a database of allele-specific sgRNA sequences for Cas9 that provide near genome-wide coverage of heterozygous sites through either direct or indirect targeting. This approach will be useful in probing the adaptive role of LOH events in this important human pathogen.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Disease and Microbiome Program, Broad Institute of MIT and Harvard, Cambridge, MA 02142, United States.
- Department of Molecular Microbiology and Immunology, Brown University, Providence, RI 02912, United States.
- Department of Molecular and Cellular Biology, University of Guelph, Guelph, ON N1G 2W1, Canada.
ORCID-Profile: Philippe C Després, Nicholas C Gervais, Meea Fogal, Christina A Cuomo, Rebecca S Shapiro
Förderung
- M.F.
- CIHR
- Canada Research Chair
- C.A.C.
- N.C.G.
- CIFAR
- NIAID NIH HHS
- NSERC
Zitieren
APA
Després, P. C., Gervais, N. C., Fogal, M., Rogers, R. K. J., Cuomo, C. A., & Shapiro, R. S. (2025). Targeted loss of heterozygosity in Candida albicans using CRISPR-Cas9 reveals the functional impact of allelic variation. GENETICS. https://doi.org/10.1093/genetics/iyaf154
Vancouver
Després PC, Gervais NC, Fogal M, Rogers RKJ, Cuomo CA, Shapiro RS. Targeted loss of heterozygosity in Candida albicans using CRISPR-Cas9 reveals the functional impact of allelic variation. GENETICS. 2025. doi:10.1093/genetics/iyaf154
BibTeX
@article{Desprs2025,
author = {Després, Philippe C and Gervais, Nicholas C and Fogal, Meea and Rogers, Ruby K J and Cuomo, Christina A and Shapiro, Rebecca S},
title = {Targeted loss of heterozygosity in Candida albicans using CRISPR-Cas9 reveals the functional impact of allelic variation},
journal = {GENETICS},
year = {2025},
doi = {10.1093/genetics/iyaf154}
}
EUVIMED